Overview
RNAZ market data
Price History
RNAZ price chart · 1M
- O
- 3.40
- H
- 3.40
- L
- 3.40
- C
- 3.40
- Vol
- 0.000000
- Source
- US equities market feed
- Observed
- Aug 21, 2026, 12:00 AM
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $3.40
- Previous Close
- $3.40
- Day High
- $3.40
- Day Low
- $3.40
- 52 Week High
- $10.57
- 52 Week Low
- $3.10
- 7 Day Return
- +3.82%
- 30 Day Return
- -59.29%
- 90 Day Return
- -45.06%
- 1 Year Return
- -65.83%
- Daily Notional Volume
- $0 Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$50.25 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.28 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $2.87 – $20.99 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $3.7M · P/B 2.52.
Company News
12 Health Care Stocks Moving In Monday's After-Market SessionBenzinga · Aug 17, 2026, 9:06 PM
8-K filing — Transcode Therapeutics, Inc. (RNAZ)SEC EDGAR · Aug 3, 2026, 8:15 PM